Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2007
10/24/2007CN101058572A Peptides compound with antineoplastic activity
10/24/2007CN101058567A Novel pharmacology acceptable salt for cinepazide
10/24/2007CN101058566A Novel medicinal salt for cinepazide and preparation method thereof
10/24/2007CN101058565A Stable cinepazide water-soluble salt
10/24/2007CN101058557A Method of preparing polyhydroxy annular nitrone
10/24/2007CN100344630C Process for preparing 2-pyrrolidinyl-3h,5h-pyrrolo[3,2-d]pyrimidine -4-ketone derivative
10/24/2007CN100344613C Preparatino method of (2S,4S)-1-(4-nitro carbobenzoyl)-2-[(3-allyloxycarbonyl)-phenyl aminoformyl]-pyrrolidine -4-thioalcohol
10/23/2007US7285681 Biguanide derivatives
10/23/2007US7284610 Acid ammonium salts of an imide of polymaleic anhydride; hydraulic fracturing fluids used in enhanced oil recovery
10/18/2007WO2007118185A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/18/2007WO2007118137A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007WO2007117591A2 Total synthesis of salinosporamide a and analogs thereof
10/18/2007WO2007117557A2 Diaminopropanol renin inhibitors
10/18/2007WO2007095980A8 Modified amino acids
10/18/2007US20070244331 reacting a thiocarbonate with N-hydroxysuccinimide in the presence of an oxidant, to form an 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonate, used as prodrugs of primary or secondary amine-containing drugs, such as pregabalin or tranexamic acid
10/18/2007US20070244328 Organocatalysts and Methods of Use in Chemical Synthesis
10/18/2007US20070244317 Hydrogenation of maleic acid in the presence of water and methyl amine to produce N-methylpyrrolidone using a catalyst of ruthenium or osmium; and an organic phosphine such as triphos; cost effective route to lactams
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244184 Glycosidase inhibitors and methods of synthesizing same
10/18/2007US20070244170 Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity
10/18/2007US20070244156 Sulfonylamino-acetic acid derivatives
10/18/2007US20070244122 Derivatives of sulindac, use thereof and preparation thereof
10/18/2007US20070244007 Cis-Alkoxyspiro-Substituted Tetramic Acid Derivatives
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/18/2007CA2648804A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007CA2648317A1 Total synthesis of salinosporamide a and analogs thereof
10/18/2007CA2646069A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007EP1843767A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders.
10/17/2007EP1742909A4 Anionic-sweetener-based ionic liquids and methods of use thereof
10/17/2007EP1368315B1 Method for preparing amlodipine
10/17/2007CN101056893A N-substituted imides as polymerization initiators
10/17/2007CN101056852A Iodine-phenyl-substituted cyclic cetoenols
10/17/2007CN101056845A Substituted aniline derivatives
10/17/2007CN101054360A Method for preparing N-substituted acryloyl-2,5-pyrrole-dione compound
10/17/2007CN101054359A Method for synthesizing 2-pyrrole methyl formate
10/17/2007CN101054358A Method for synthesizing pentanary heterocycle methyl formate
10/17/2007CN100343289C Process for forming polyalkenyl acylating agents
10/17/2007CN100343231C Dipyrrolinone subunit compound, coloring agent containing said compound and its preparation method
10/16/2007US7282590 Drug conjugates
10/16/2007US7282517 Method of manufacturing glimepiride and the respective intermediate
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/11/2007WO2007114921A2 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5] decan-2-one and treatment methods using the same
10/11/2007WO2007114338A1 Acid secretion inhibitor
10/11/2007WO2007113634A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007WO2007113575A2 Reagents and methods for cross-linking biological molecules
10/11/2007WO2007113327A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
10/11/2007WO2007113155A1 Process for preparation of enantiomerically enriched cyclic β-aryl or heteroaryl carboxylic acids
10/11/2007WO2007112669A1 Dicyclooctane derivates, preparation processes and medical uses thereof
10/11/2007US20070238882 Process for Preparing Nitrooxy Esters, Nitrooxy Thioesters Nitrooxy Carbonates and Nitrooxy Thiocarbinates, Intermediates Useful in Said Process and Preparation Thereof
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238754 1-Cyclohexylmethyl-5-(2,5-dimethoxy-phenyl)-2-methyl-1H-pyrrole-3-carboxylic acid cyclohexylamide and 2-(5-Chloro-2-methoxy-phenyl)-1-(2-cyclohexyl-ethyl)-5-methyl-1H-imidazole-4-carboxylic acid cyclohexylamide; treating obesity, eating disorders; antidiabetic agents; antiinflammatory agents; drug abuse
10/11/2007US20070238753 Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007CA2682846A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007CA2648640A1 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
10/11/2007CA2648246A1 Process for preparation of enantiomerically enriched cyclic .beta.-aryl or heteroaryl carboxylic acids
10/11/2007CA2648028A1 Bicyclooctane derivatives, preparation process and pharmaceutical use thereof
10/11/2007CA2647862A1 Acid secretion inhibitor
10/10/2007EP1842845A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
10/10/2007EP1842841A1 Process for production of fluoro derivative
10/10/2007EP1841733A2 Substituted pyrrolidone compounds as prostaglandin ep4 agonists
10/10/2007EP1841504A2 Substituted biaryl compounds as factor xia inhibitors
10/10/2007EP1841425A2 Phenyl-substituted pyrrolidones
10/10/2007EP1841424A2 Synthesis of aryl pyrrolidones
10/10/2007EP1756119B1 Collection of traceable compounds and uses thereof
10/10/2007EP1399163B1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007CN101050196A Bronsted acidic compound of containing L¿C proline radical, preparation method, and application
10/10/2007CN101050195A Compound of containing cation radical of L ¿C proline, preparation method, and application
10/10/2007CN101050194A Derivative of bicyclo-octanes class, preparation method, and application of medicine
10/10/2007CN100341870C Glycosidase inhibitors and preparation thereof
10/09/2007US7279584 Method for production of cis-4-fluoro-L-proline derivatives
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279578 Use as orexin receptor antagonists, depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis; depressive neurosis; anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; schizophrenia; manic depression; delerium
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279491 Phenylpiperidines and phenylpyrrolidines
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279444 for controlling undesirable plants
10/04/2007WO2007111238A1 Oral agent for promoting synthesis of tissue collagen
10/04/2007WO2007111024A1 Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative
10/04/2007WO2007110449A1 Benzenesulfonamide compounds and their use
10/04/2007WO2007056167A3 Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
10/04/2007WO2006108693A8 Process for preparing bicyclic compounds
10/04/2007US20070232684 Compounds for inhibition of HIV infection by blocking HIV entry
10/04/2007US20070232683 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof
10/04/2007US20070232664 Iron binding agents
10/04/2007US20070232608 Prophylaxis of diabetes; (1SR,3RS)-3-{2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethylamino}cyclopentane-1-carboxamide; non-insulin dependent diabetes mellitus, impaired glucose homeostasis, impaired glucose tolerance, infertility, polycystic ovary syndrome
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232581 Alzheimer's disease; compounds inhibit the production of A beta -peptide; improved pharmacokinetics; N-((4-amino-3,5-dichlorobenzylamino)(amino)methylene)-3-(isobutoxyimino)-3-(4-methoxyphenyl)propanamide
10/04/2007US20070231839 N-(3-oxododecanoyl)-L-homoserine lactone, binding to carrier; used as vaccine or to raise and subsequently isolate antibodies or binding portions thereof which are capable of recognizing and binding to the autoinducer; carrier molecule comprises a lysine-containing protein, such as bovine serum albumin
10/04/2007CA2647038A1 Inhibitors of protein prenyltransferases
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1838702A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
10/03/2007EP1838694A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
10/03/2007EP1838660A2 New one-step synthesis of useful disubstituted amines
10/03/2007EP1663232B1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
10/03/2007EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 404